Compass Therapeutics Q2 EPS $(0.08) Up From $(1.07) YoY

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.08) per share. This is a 92.52 percent increase over losses of $(1.07) per share from the same period last year.

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.08) per share. This is a 92.52 percent increase over losses of $(1.07) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Rapper 50 Cent Accepted Bitcoin For His Album ‘Animal Ambition’ 10 Years Ago: Here’s How Much He Earned In Crypto And What It’s Worth Now

Grammy Award-winning rapper 50 Cent became the first artist to accept Bitcoin (CRYPTO: BTC) as payment 10 years ago for his album "Animal Ambition" — and boy, oh boy, was he a visionary. The astronomical rise of Bitcoin has made him a multi-millionaire today.

BTC